NCT00790439: Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant |
|
|
| Withdrawn | 2 | 0 | US | Low Molecular Weight Sulfated Dextran, LMW-SD, Heparin, Heparin Sodium, Mycophenolate Mofetil, MMF, Mycophenolate, Mycophenolic Acid, CellCept, Sirolimus, Rapamune, Tacrolimus, Hecoria, Cyclosporine, Ciclosporin, GENGRAF® Capsules, Daclizumab, Basiliximab, Simulect ®, Allogeneic Pancreatic Islet Cells | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type I | 10/09 | 10/09 | | |
NCT00260689: Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia |
|
|
| Completed | 2 | 136 | US | Anti-thymocyte globulin (rabbit), Anti-thymocyte globulin (horse), Cyclosporine, Alemtuzumab, Campath | National Heart, Lung, and Blood Institute (NHLBI) | Immunosuppresion, Thrombocytopenia, Pancytopenia, Neutropenia | 05/16 | 05/16 | | |
NCT01193283: Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia |
|
|
| Completed | 1/2 | 22 | US | Cyclophosphamide, Cytoxan, Cyclosporine, Gengraf, Neoral, Sandimmune | National Heart, Lung, and Blood Institute (NHLBI) | Aplastic Anemia, Neutropenia, Pancytopenia, Severe Aplastic Anemia | 09/14 | 09/14 | | |
